1) Progressive Stroke
进展性脑卒中
1.
Progressive Stroke Treatment With Intravenous Drip of Heparin Sodium;
持续静脉滴注肝素钠治疗进展性脑卒中
2.
Objective: To study the effect of lovastatin on C-reactive protein (CRP) and soluable intercellular adhesive molecules (sICAM-1) levels in patients with progressive stroke (PS).
方法:87例脑卒中患者按病情分为进展性脑卒中62例,其中A组32例,B组30例;稳定 性脑卒中患者(C组)25例和正常组(D组)20例。
3.
Some factors,such as infection,hypotension,hyperglycaemia and fever were related with progressive stroke.
进展性脑卒中已成为临床难题之一,感染、血压过低、血糖升高、发热都可加重脑卒中的进展,临床表现、影像学、生化标志物等有助于预测进展性脑卒中的发生,治疗包括抗凝、降纤、降温、降糖、扩容、治疗脑水肿、神经保护剂、外科手术。
3) Progressive ischemic stroke
进展性缺血性脑卒中
1.
Preventive role of defibrase in progressive ischemic stroke;
降纤酶对进展性缺血性脑卒中预防作用的探讨(英文)
2.
Methods:We selected 135 cases of Progressive ischemic stroke happened from 12 hours to 48 hours,and divided into three groups randomly,who received the low molecular weight heparin,Ginkgo bilobate extract and low molecular weight heparin combined with Ginkgo bilobate extract,respectively.
目的:观察低分子肝素联合银杏达莫治疗进展性缺血性脑卒中的疗效。
4) progressive ischemic cerebral apoplexy
进展型缺血性脑卒中
1.
Objective To investigate the therapeutic effect of clopidogrel on progressive ischemic cerebral apoplexy.
目的研究氯吡格雷治疗进展型缺血性脑卒中的疗效。
5) Progressive stroke
进展性卒中
1.
Objective The pathologic physiology and UK that analysis research lack the guts the progressive stroke unites with low mark sub- heparin the mechanism of the treatment.
目的分析研究缺血性进展性卒中的病理生理及尿激酶与低分子肝素联合治疗的机理。
2.
Progressive stroke is higher in ischemic cerebrovascular diseases.
进展性卒中在缺血性脑血管病中发生率高。
6) Stroke in progression
进展性卒中
1.
Objective To study the level of plasma lysophosphatidic acid(LPA) in patients with acute cerebral thrombosis and to explore the mechanism of the stroke in progression .
0001);进展性卒中组血浆水平 10。
补充资料：连续性与非连续性(见间断性与不间断性)
连续性与非连续性(见间断性与不间断性)
continuity and discontinuity
11an父ux泊g四f“山。麻以角g、.连续性与非连续性(c。nt，n琳t:nuity一)_见间断性与不间断性。and diseo红ti-
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条